Dariusz Mirosław Kowalski

28PUBLICATIONS
127CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Immunogenetics (incl. genetic immunology)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersOncology and carcinogenesis not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Oct 28, 2026
KEYNOTE-867: A Phase III, Randomized, Double-Blind Study of Stereotactic Body Radiotherapy With Pembrolizumab for Unresected Stage I or II Non-Small Cell Lung Cancer.

|Sep 26, 2026
Immune Checkpoint Inhibitor-Related Pancreatic Injury in Patients with Lung Cancer: Diagnostic Challenges, Multidisciplinary Management, and Outcomes.

|Jun 03, 2026
Participant-Reported Preference for Pembrolizumab Administered Subcutaneously or Intravenously: A Randomized, Open-Label, Phase II Study.

|Feb 24, 2026
Five-Year Clinical Outcomes With Nivolumab Plus Ipilimumab Versus Chemotherapy as First-Line Treatment for Unresectable Pleural Mesothelioma in CheckMate 743.

Arnaud Scherpereel, Paul Baas, Anna K Nowak

|Dec 30, 2025
Clinicopathologic Characteristics, Treatment Outcomes, and Survival in Thymic Neuroendocrine Neoplasms (t-NEN): A 25-Year Single-Center Experience.

Aleksandra Piórek, Adam Płużański, Dariusz M Kowalski

|Nov 26, 2025
Radiation Recall Pneumonitis with Pneumocystis jirovecii Superinfection and Treatment Induced Hyponatremia in a Patient with Non-Small-Cell Lung Cancer.

Aleksandra Piórek, Adam Płużański, Dariusz M Kowalski

Pageof 5

Frequent Collaborators

8 joint publications

Adam Płużański

8 joint publications

Aleksandra Piórek

7 joint publications

Maciej Krzakowski

6 joint publications

Magdalena Knetki-Wróblewska